This is a preview of subscription content, log in via an institution to check access.
Reference
Parkinson B, et al. Real-World Evidence: A Comparison of the Australian Herceptin Program and Clinical Trials of Trastuzumab for HER2-Positive Metastatic Breast Cancer. PharmacoEconomics : 20 May 2016. Available from: URL: http://doi.org/10.1007/s40273-016-0411-2
Rights and permissions
About this article
Cite this article
Survival differs in Herceptin Program versus trastuzumab trials. PharmacoEcon Outcomes News 754, 30 (2016). https://doi.org/10.1007/s40274-016-3100-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3100-7